CONMED Corporation (CNMD) |
| 35.7 0.18 (0.51%) 05-29 16:00 |
| Open: | 35.345 |
| High: | 36.01 |
| Low: | 35.345 |
| Volume: | 232,247 |
| Market Cap: | 1,075(M) |
| PE Ratio: | 20.17 |
| Exchange: | New York Stock Exchange |
| Industry: | Medical - Devices |
| Sector: | Healthcare |
| Technical analysis | ||||
![]() |
||||
| sell | buy | |||
| Resistance 2: | 40.18 |
| Resistance 1: | 38.02 |
| Pivot price: | 36.14 |
| Support 1: | 34.52 |
| Support 2: | 28.72 |
| 52w High: | 60.35 |
| 52w Low: | 33.21 |
CONMED Corporation, a medical technology company, develops, manufactures, and sells surgical devices and related equipment for surgical procedures worldwide. It offers orthopedic surgery products, including TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-knot All-Suture Anchors, and PopLok Knotless Suture Anchors, which provide unique clinical solutions to orthopedic surgeons for the repair of soft tissue injuries, as well as supporting products that enable surgeons to perform minimally invasive sports medicine surgeries. The company markets orthopedic surgery products under the Hall, CONMED Linvatec, Concept, and Shutt brands. It also offers general surgery products, such as clinical insufflation, smoke evacuation, electrosurgical, and endomechanical products; and endoscopic technologies, including diagnostic and therapeutic products for use in gastroenterology procedures, and products for the treatment of diseases of the biliary structures, as well as cardiac monitoring products comprising ECG and EEG electrodes, and cardiac defibrillation pads. The company markets its products directly to hospitals, surgery centers, and other healthcare institutions, as well as through medical specialty distributors. CONMED Corporation was incorporated in 1970 and is headquartered in Largo, Florida.
| EPS | 1.770 |
| Book Value | 33.760 |
| PEG Ratio | 1.84 |
| Gross Profit | 24.609 |
| Profit Margin (%) | 4.00 |
| Operating Margin (%) | 10.01 |
| Return on Assets (ttm) | 3.7 |
| Return on Equity (ttm) | 5.5 |
Fri, 29 May 2026
Why Is Conmed (CNMD) Down 3.1% Since Last Earnings Report? - Yahoo Finance
Wed, 27 May 2026
Board Refresh And Bylaw Changes Might Change The Case For Investing In CONMED (CNMD) - simplywall.st
Wed, 20 May 2026
New CONMED (NYSE: CNMD) directors, bylaw changes and 2026 vote outcomes - Stock Titan
Wed, 20 May 2026
CONMED Corporation Appoints Celine Martin and Jeff Mirviss to its Board of Directors - Business Wire
Thu, 14 May 2026
Is the Options Market Predicting a Spike in CONMED Stock? - Yahoo Finance UK
Tue, 05 May 2026
Why CONMED (CNMD) Is Down 5.3% After Raising 2026 Outlook And Exiting Gastroenterology Portfolio - simplywall.st
|
StockChart iOS |
StoxlineLite iOS |
StoxlineLite iOS |
OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |